These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 19616536)

  • 1. MDMA-induced serotonergic neurotoxicity enhances aggressiveness in low- but not high-aggressive rats.
    Wallinga AE; ten Voorde AM; de Boer SF; Koolhaas JM; Buwalda B
    Eur J Pharmacol; 2009 Sep; 618(1-3):22-7. PubMed ID: 19616536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term neuronal damage and recovery after a single dose of MDMA: expression and distribution of serotonin transporter in the rat brain.
    Kirilly E
    Neuropsychopharmacol Hung; 2010 Sep; 12(3):413-23. PubMed ID: 20962361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
    Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
    J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X; Baumann MH; Xu H; Rothman RB
    Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: temporal, spatial, and cellular patterns.
    Adori C; Andó RD; Kovács GG; Bagdy G
    J Comp Neurol; 2006 Jul; 497(2):251-69. PubMed ID: 16705678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low ambient temperature reveals distinct mechanisms for MDMA-induced serotonergic toxicity and astroglial Hsp27 heat shock response in rat brain.
    Adori C; Andó RD; Balázsa T; Soti C; Vas S; Palkovits M; Kovács GG; Bagdy G
    Neurochem Int; 2011 Oct; 59(5):695-705. PubMed ID: 21756954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy.
    Colado MI; O'Shea E; Granados R; Misra A; Murray TK; Green AR
    Br J Pharmacol; 1997 Jun; 121(4):827-33. PubMed ID: 9208155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the effect of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") on the subsequent long-term behaviour of rats in the plus maze and open field.
    Mechan AO; Moran PM; Elliott M; Young AJ; Joseph MH; Green R
    Psychopharmacology (Berl); 2002 Jan; 159(2):167-75. PubMed ID: 11862345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of acute brain tyrosine depletion on MDMA-induced changes in brain 5-HT.
    Rodsiri R; Green AR; Marsden CA; Fone KC
    J Psychopharmacol; 2010 Feb; 24(2):267-74. PubMed ID: 19965941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDMA treatment 6 months earlier attenuates the effects of CP-94,253, a 5-HT1B receptor agonist, on motor control but not sleep inhibition.
    Gyongyosi N; Balogh B; Kirilly E; Kitka T; Kantor S; Bagdy G
    Brain Res; 2008 Sep; 1231():34-46. PubMed ID: 18638459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine(1A) receptor agonist.
    Piper BJ; Vu HL; Safain MG; Oliver AJ; Meyer JS
    J Pharmacol Exp Ther; 2006 May; 317(2):838-49. PubMed ID: 16434566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term neurobiological consequences of ecstasy: a role for pre-existing trait-like differences in brain monoaminergic functioning?
    Wallinga AE; de Boer SF; Granneman RA; Koolhaas JM; Buwalda B
    Pharmacol Biochem Behav; 2009 Dec; 94(2):227-33. PubMed ID: 19699758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin transporter expression is not sufficient to confer cytotoxicity to 3,4-methylenedioxymethamphetamine (MDMA) in vitro.
    Hayat S; Williams RJ; Rattray M
    J Psychopharmacol; 2006 Mar; 20(2):257-63. PubMed ID: 16510483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a serotonin depleting regimen of 3,4-methylenedioxymethamphetamine (MDMA) on the subsequent stimulation of acetylcholine release in the rat prefrontal cortex.
    Nair SG; Gudelsky GA
    Brain Res Bull; 2006 Apr; 69(4):382-7. PubMed ID: 16624669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
    Green AR; Mechan AO; Elliott JM; O'Shea E; Colado MI
    Pharmacol Rev; 2003 Sep; 55(3):463-508. PubMed ID: 12869661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats.
    Clemens KJ; Cornish JL; Li KM; Hunt GE; McGregor IS
    Neuropharmacology; 2005 Aug; 49(2):195-207. PubMed ID: 15993443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preexposure to MDMA ("Ecstasy") delays acquisition but facilitates MDMA-induced reinstatement of amphetamine self-administration behavior in rats.
    Morley KC; Cornish JL; Li KM; McGregor IS
    Pharmacol Biochem Behav; 2004 Oct; 79(2):331-42. PubMed ID: 15501310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDMA self-administration in rats: acquisition, progressive ratio responding and serotonin transporter binding.
    Schenk S; Hely L; Lake B; Daniela E; Gittings D; Mash DC
    Eur J Neurosci; 2007 Dec; 26(11):3229-36. PubMed ID: 18005064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.